All the animal experiments were performed in compliance with the guidelines of the Institute of Experimental Animal Sciences.
The animals were maintained and treated in compliance with the guidelines of the Swiss Veterinary Office and the Cantonal Veterinary office of Basel-Stadt (approval 2085 and 789).
Experimental procedures were conducted in compliance with the guidelines of the international council for laboratory animals science for the use of laboratory animals.
All animal experiments were carried out in compliance with the guidelines of the Canadian Council on Animal Care and with approval from the local Animal Care Committee of the Cross Cancer Institute under the protocol number AC 11183.
All animal experiments were conducted in compliance with the guidelines of the Canadian Council on Animal Care CCACC) and with approval from the Animal Care Committee (ACC) at the University of Ottawa.
All animal experimentations were executed in compliance with the guidelines of the Committee for the Purpose of Control and Supervision of Experimental Animals (CPCSEA), New Delhi, Government of India.
All the animal experiments were carried out in the Beijing Center for Drug Safety Evaluation, in accordance with a protocol approved by the Institutional Animal Care and Use Committee of the Center, which is in compliance with the guidelines of the Association for Assessment and Accreditation of Laboratory Animal Care International.
The study was conducted after approval and in compliance with the guidelines of the ethical committee.
All animal infection procedures were in compliance with the guidelines of the Institutional Animal Care and Use Committee (IACUC).
Animal treatment was in compliance with the Guidelines of the International Association for the Study of Pain [68].
Animal experiments in the present study were performed in compliance with the guidelines of the Institute for Laboratory Animal Research, National Cancer Center Research Institute.
